{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:58:50Z","timestamp":1788829130526,"version":"build-2803163510"},"reference-count":185,"publisher":"Springer Science and Business Media LLC","issue":"21","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,6,11]]},"DOI":"10.1038\/s41388-026-03815-8","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T10:52:51Z","timestamp":1778496771000},"page":"1955-1969","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The microbiome across the prostate disease continuum: from health and BPH to prostatitis\/CPPS and cancer"],"prefix":"10.1038","volume":"45","author":[{"given":"Bisheng","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1531-4948","authenticated-orcid":false,"given":"Lanqi","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1215-2912","authenticated-orcid":false,"given":"Zongwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2013-073X","authenticated-orcid":false,"given":"Hai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4485-6017","authenticated-orcid":false,"given":"Xinyuan","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"3815_CR1","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/s41564-025-02035-2","volume":"10","author":"N Fierer","year":"2025","unstructured":"Fierer N, Leung PM, Lappan R, Eisenhofer R, Ricci F, Holland SI, et al. Guidelines for preventing and reporting contamination in low-biomass microbiome studies. Nat Microbiol. 2025;10:1570\u201380.","journal-title":"Nat Microbiol"},{"key":"3815_CR2","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41586-022-04480-z","volume":"603","author":"D Paik","year":"2022","unstructured":"Paik D, Yao L, Zhang Y, Bae S, D\u2019Agostino GD, Zhang M, et al. Human gut bacteria produce \u03a4(\u0397)17-modulating bile acid metabolites. Nature. 2022;603:907\u201312.","journal-title":"Nature"},{"key":"3815_CR3","unstructured":"Pendegast HJ, Leslie SW, Rosario DJ. Chronic prostatitis and chronic pelvic pain syndrome in men. Treasure Island (FL): StatPearls Publishing LLC.; 2025."},{"key":"3815_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45332-w","volume":"15","author":"G Lachance","year":"2024","unstructured":"Lachance G, Robitaille K, Laaraj J, Gevariya N, Varin TV, Feldiorean A, et al. The gut microbiome-prostate cancer crosstalk is modulated by dietary polyunsaturated long-chain fatty acids. Nat Commun. 2024;15:3431.","journal-title":"Nat Commun"},{"key":"3815_CR5","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/JU.0000000000004564","volume":"214","author":"HH Lai","year":"2025","unstructured":"Lai HH, Pontari MA, Argoff CE, Bresler L, Breyer BN, Chou R, et al. Male chronic pelvic pain: AUA guideline: part I evaluation and management approach. J Urol. 2025;214:116\u201326.","journal-title":"J Urol"},{"key":"3815_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","volume":"9","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Meng Y, Li D, Yao L, Le J, Liu Y, et al. Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies. Signal Transduct Target Ther. 2024;9:55.","journal-title":"Signal Transduct Target Ther"},{"key":"3815_CR7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41423-023-00987-1","volume":"20","author":"CH Kim","year":"2023","unstructured":"Kim CH. Complex regulatory effects of gut microbial short-chain fatty acids on immune tolerance and autoimmunity. Cell Mol Immunol. 2023;20:341\u201350.","journal-title":"Cell Mol Immunol"},{"key":"3815_CR8","doi-asserted-by":"publisher","first-page":"116735","DOI":"10.1016\/j.biopha.2024.116735","volume":"175","author":"D-H Lee","year":"2024","unstructured":"Lee D-H, Kim M-T, Han J-H. GPR41 and GPR43: From development to metabolic regulation. Biomed Pharmacother. 2024;175:116735.","journal-title":"Biomed Pharmacother"},{"key":"3815_CR9","doi-asserted-by":"crossref","unstructured":"Stein RA, Riber L. Epigenetic effects of short-chain fatty acids from the large intestine on host cells. microLife. 2023;4:uqad032.","DOI":"10.1093\/femsml\/uqad032"},{"key":"3815_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41392-024-01811-6","volume":"9","author":"JS Fleishman","year":"2024","unstructured":"Fleishman JS, Kumar S. Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets. Signal Transduct Target Ther. 2024;9:97.","journal-title":"Signal Transduct Target Ther"},{"key":"3815_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2023.101805","volume":"77","author":"P Pavlo","year":"2023","unstructured":"Pavlo P, Kamyshna I, Kamyshnyi A. Effects of metformin on the gut microbiota: a systematic review. Mol Metab. 2023;77:101805.","journal-title":"Mol Metab"},{"key":"3815_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1346035","volume":"15","author":"VJ Ashonibare","year":"2024","unstructured":"Ashonibare VJ, Akorede BA, Ashonibare PJ, Akhigbe TM, Akhigbe RE. Gut microbiota-gonadal axis: the impact of gut microbiota on reproductive functions. Front Immunol. 2024;15:1346035.","journal-title":"Front Immunol"},{"key":"3815_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04115-5","volume":"21","author":"Z Zheng","year":"2023","unstructured":"Zheng Z, Hu J, Li W, Ma K, Zhang C, Li K, et al. Integrated microbiome and metabolome analysis reveals novel urinary microenvironmental signatures in interstitial cystitis\/bladder pain syndrome patients. J Transl Med. 2023;21:266.","journal-title":"J Transl Med"},{"key":"3815_CR14","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.3389\/fcimb.2023.1308665","volume":"13","author":"NS Elsayed","year":"2024","unstructured":"Elsayed NS, Wolfe AJ, Burk RD. Urine microbiome in individuals with an impaired immune system. Front Cell Infect Microbiol. 2024;13:2023.","journal-title":"Front Cell Infect Microbiol"},{"key":"3815_CR15","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.3389\/fcimb.2023.1210161","volume":"13","author":"NS Deen","year":"2023","unstructured":"Deen NS, Ahmed A, Tasnim NT, Khan N. Clinical relevance of expanded quantitative urine culture in health and disease. Front Cell Infect Microbiol. 2023;13:2023.","journal-title":"Front Cell Infect Microbiol"},{"key":"3815_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110668","volume":"27","author":"\u00c7 Ak","year":"2024","unstructured":"Ak \u00c7, Sayar Z, Thibault G, Burlingame EA, Kuykendall MJ, Eng J, et al. Multiplex imaging of localized prostate tumors reveals altered spatial organization of AR-positive cells in the microenvironment. iScience. 2024;27:110668.","journal-title":"iScience"},{"key":"3815_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116250","volume":"44","author":"X Li","year":"2025","unstructured":"Li X, Chu X, Xu W, Yang Y, Wei T, Bo Y, et al. Integrated spatial transcriptomic profiling to dissect the cellular characteristics of tumor-associated tertiary lymphoid structures. Cell Rep. 2025;44:116250.","journal-title":"Cell Rep"},{"key":"3815_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54364-1","volume":"15","author":"A Kiviaho","year":"2024","unstructured":"Kiviaho A, Eerola SK, Kallio HML, Andersen MK, Hoikka M, Tiihonen AM, et al. Single cell and spatial transcriptomics highlight the interaction of club-like cells with immunosuppressive myeloid cells in prostate cancer. Nat Commun. 2024;15:9949.","journal-title":"Nat Commun"},{"key":"3815_CR19","unstructured":"Deem SG. Acute bacterial prostatitis. Medscape. Updated November 6, 2024. Available from: https:\/\/emedicine.medscape.com\/article\/2002872-overview."},{"key":"3815_CR20","first-page":"2023","volume":"14","author":"T Wang","year":"2023","unstructured":"Wang T, Hu Y, Dusi S, Qi F, Sartoris S, Ugel S, et al. Open \u201cSesame\u201d to the complexity of pattern recognition receptors of myeloid-derived suppressor cells in cancer. Front Immunol. 2023;14:2023.","journal-title":"Front Immunol"},{"key":"3815_CR21","doi-asserted-by":"crossref","unstructured":"Wang K, Ait-Ahmad K, Kupp SD, Sims Z, Cramer E, Sayar Z et al. UniFORM: towards universal immunofluorescence normalization for multiplex tissue imaging. bioRxiv 2024. https:\/\/www.biorxiv.org\/content\/10.1101\/2024.12.06.626879v1.","DOI":"10.1101\/2024.12.06.626879"},{"key":"3815_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.eururo.2024.08.025","volume":"87","author":"S Figiel","year":"2025","unstructured":"Figiel S, Bates A, Braun DA, Eapen R, Eckstein M, Manley BJ, et al. Clinical implications of basic research: exploring the transformative potential of spatial \u2018omics in uro-oncology. Eur Urol. 2025;87:8\u201314.","journal-title":"Eur Urol"},{"key":"3815_CR23","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/pros.24684","volume":"84","author":"M Shahait","year":"2024","unstructured":"Shahait M, Hakansson AK, Daniel RE, Hosny K, Davicioni E, Liu SY, et al. Quantification and molecular correlates of tertiary lymphoid structures in primary prostate cancer. Prostate. 2024;84:709\u201316.","journal-title":"Prostate"},{"key":"3815_CR24","doi-asserted-by":"crossref","unstructured":"Facchin S, Bertin L, Bonazzi E, Lorenzon G, De Barba C, Barberio B et al. Short-chain fatty acids and human health: from metabolic pathways to current therapeutic implications. Life. 2024;14:559.","DOI":"10.3390\/life14050559"},{"key":"3815_CR25","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s42255-024-01191-9","volume":"7","author":"M Nshanian","year":"2025","unstructured":"Nshanian M, Gruber JJ, Geller BS, Chleilat F, Lancaster SM, White SM, et al. Short-chain fatty acid metabolites propionate and butyrate are unique epigenetic regulatory elements linking diet, metabolism and gene expression. Nat Metab. 2025;7:196\u2013211.","journal-title":"Nat Metab"},{"key":"3815_CR26","doi-asserted-by":"publisher","first-page":"115276","DOI":"10.1016\/j.biopha.2023.115276","volume":"165","author":"H Duan","year":"2023","unstructured":"Duan H, Wang L, Huangfu M, Li H. The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: mechanisms and therapeutic potentials. Biomed Pharmacother. 2023;165:115276.","journal-title":"Biomed Pharmacother"},{"key":"3815_CR27","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1111\/jcmm.17924","volume":"27","author":"R Gudneppanavar","year":"2023","unstructured":"Gudneppanavar R, Sabu Kattuman EE, Teegala LR, Southard E, Tummala R, Joe B, et al. Epigenetic histone modification by butyrate downregulates KIT and attenuates mast cell function. J Cell Mol Med. 2023;27:2983\u201394.","journal-title":"J Cell Mol Med"},{"key":"3815_CR28","doi-asserted-by":"crossref","unstructured":"Miya TV, Marima R, Damane BP, Ledet EM, Dlamini Z. Dissecting microbiome-derived SCFAs in prostate cancer: analyzing gut microbiota, racial disparities, and epigenetic mechanisms. Cancers. 2023;15:4086.","DOI":"10.3390\/cancers15164086"},{"key":"3815_CR29","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.3390\/cancers17071064","volume":"17","author":"W-A Kwon","year":"2025","unstructured":"Kwon W-A, Joung JY. Immunotherapy in prostate cancer: from a \u201ccold\u201d tumor to a \u201chot\u201d prospect. Cancers. 2025;17:1064.","journal-title":"Cancers"},{"key":"3815_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1607899","volume":"12","author":"G Song","year":"2025","unstructured":"Song G, Xie Y, Yi L, Cheng W, Jia H, Shi W, et al. Bile acids affect intestinal barrier function through FXR and TGR5. Front Med. 2025;12:1607899.","journal-title":"Front Med"},{"key":"3815_CR31","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/s41590-022-01284-1","volume":"23","author":"A Jarade","year":"2022","unstructured":"Jarade A, Garcia Z, Marie S, Demera A, Prinz I, Bousso P, et al. Inflammation triggers ILC3 patrolling of the intestinal barrier. Nat Immunol. 2022;23:1317\u201323.","journal-title":"Nat Immunol"},{"key":"3815_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-023-01486-1","volume":"11","author":"JS Mar","year":"2023","unstructured":"Mar JS, Ota N, Pokorzynski ND, Peng Y, Jaochico A, Sangaraju D, et al. IL-22 alters gut microbiota composition and function to increase aryl hydrocarbon receptor activity in mice and humans. Microbiome. 2023;11:47.","journal-title":"Microbiome"},{"key":"3815_CR33","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/s41586-023-06508-4","volume":"621","author":"BG Wiggins","year":"2023","unstructured":"Wiggins BG, Wang Y-F, Burke A, Grunberg N, Vlachaki Walker JM, Dore M, et al. Endothelial sensing of AHR ligands regulates intestinal homeostasis. Nature. 2023;621:821\u20139.","journal-title":"Nature"},{"key":"3815_CR34","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3389\/fimmu.2025.1668173","volume":"16","author":"H Kang","year":"2025","unstructured":"Kang H, Chen Z, Wang B, Chen Z. The AhR\/IL-22 axis in chronic gut inflammation: unraveling mechanisms and therapeutic prospects. Front Immunol. 2025;16:2025.","journal-title":"Front Immunol"},{"key":"3815_CR35","volume":"16","author":"G Singh","year":"2024","unstructured":"Singh G, Trehan S, Singh A, Goswami K, Farooq A, Antil P, et al. Aryl hydrocarbon receptor signaling in prostate cancer therapy: a review of implications for anti-androgen treatment strategies and resistance. Cureus. 2024;16:e65247.","journal-title":"Cureus"},{"key":"3815_CR36","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/21541264.2024.2334106","volume":"16","author":"J Proch\u00e1zkov\u00e1","year":"2025","unstructured":"Proch\u00e1zkov\u00e1 J, Kahounov\u00e1 Z, Vondr\u00e1\u010dek J, Sou\u010dek K. Aryl hydrocarbon receptor as a drug target in advanced prostate cancer therapy - obstacles and perspectives. Transcription. 2025;16:47\u201366.","journal-title":"Transcription"},{"key":"3815_CR37","doi-asserted-by":"publisher","DOI":"10.37349\/emed.2025.1001339","volume":"6","author":"Z Wang","year":"2025","unstructured":"Wang Z, Man S, Koeth R. TMAO metaorganismal pathway and chronic inflammatory diseases. Exploration Med. 2025;6:1001339.","journal-title":"Exploration Med"},{"key":"3815_CR38","doi-asserted-by":"crossref","unstructured":"Caradonna E, Abate F, Schiano E, Paparella F, Ferrara F, Vanoli E et al. Trimethylamine-N-oxide (TMAO) as a rising-star metabolite: implications for human health. Metabolites. 2025;15:220.","DOI":"10.3390\/metabo15040220"},{"key":"3815_CR39","first-page":"2025","volume":"16","author":"J-Y Wu","year":"2025","unstructured":"Wu J-Y, Zeng Y, You Y-Y, Chen Q-Y. Polyamine metabolism and anti-tumor immunity. Front Immunol. 2025;16:2025.","journal-title":"Front Immunol"},{"key":"3815_CR40","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1021\/acssensors.4c03250","volume":"10","author":"P Dehghani","year":"2025","unstructured":"Dehghani P, Salehirozveh M, Tajabadi A, Yeung CC, Lam M, Leung HY, et al. Next-gen point-of-care tool for ultra-sensitive detection of urinary spermine for prostate cancer diagnosis. ACS Sens. 2025;10:2640\u201351.","journal-title":"ACS Sens"},{"key":"3815_CR41","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/08830185.2021.1955876","volume":"41","author":"H-c Zhou","year":"2022","unstructured":"Zhou H-c, Yan X-y, Yu W-w, Liang X-q, Du X-y, Liu Z-c, et al. Lactic acid in macrophage polarization: the significant role in inflammation and cancer. Int Rev Immunol. 2022;41:4\u201318.","journal-title":"Int Rev Immunol"},{"key":"3815_CR42","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1038\/s41590-024-01999-3","volume":"25","author":"RM Peralta","year":"2024","unstructured":"Peralta RM, Xie B, Lontos K, Nieves-Rosado H, Spahr K, Joshi S, et al. Dysfunction of exhausted T cells is enforced by MCT11-mediated lactate metabolism. Nat Immunol. 2024;25:2297\u2013307.","journal-title":"Nat Immunol"},{"key":"3815_CR43","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.immuni.2025.02.008","volume":"58","author":"A Llibre","year":"2025","unstructured":"Llibre A, Kucuk S, Gope A, Certo M, Mauro C. Lactate: a key regulator of the immune response. Immunity. 2025;58:535\u201354.","journal-title":"Immunity"},{"key":"3815_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70308","volume":"6","author":"N Maihemuti","year":"2025","unstructured":"Maihemuti N, Shi Y, Zhang K, Jiang X, Chu J, Xu Y, et al. Toll-like receptors in the immunotherapy era: dual-edged swords of tumor immunity and clinical translation. MedComm. 2025;6:e70308.","journal-title":"MedComm"},{"key":"3815_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02380-0","volume":"24","author":"Q Wang","year":"2025","unstructured":"Wang Q, Yu Y, Zhuang J, Liu R, Sun C. Demystifying the cGAS-STING pathway: precision regulation in the tumor immune microenvironment. Mol Cancer. 2025;24:178.","journal-title":"Mol Cancer"},{"key":"3815_CR46","doi-asserted-by":"publisher","first-page":"e31290","DOI":"10.1097\/MD.0000000000031290","volume":"101","author":"X Zhuo","year":"2022","unstructured":"Zhuo X, Dai H, Yu S. The cGAS-STING pathway-related gene signature can predict patient prognosis and immunotherapy responses in prostate adenocarcinoma. Medicine. 2022;101:e31290.","journal-title":"Medicine"},{"key":"3815_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1601756","volume":"16","author":"H Xavier","year":"2025","unstructured":"Xavier H, Gireesh AGM, Thomas JA, Suboj P, Suresh A, Biju E, et al. Chemokines: humble yet mighty players in the tumour microenvironment. Front Immunol. 2025;16:1601756.","journal-title":"Front Immunol"},{"key":"3815_CR48","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.3390\/biology14111491","volume":"14","author":"H Hudgins","year":"2025","unstructured":"Hudgins H, Molina V, Wiernicki S, Okwuegbe K, Feng X, Wang H. Targeting C3a and C5a signaling\u2014a game changer for cancer therapy? Biology. 2025;14:1491.","journal-title":"Biology"},{"key":"3815_CR49","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41392-025-02242-7","volume":"10","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Shen G, Zhou X, Li J. Therapeutic potential of tumor-associated neutrophils: dual role and phenotypic plasticity. Signal Transduct Target Ther. 2025;10:178.","journal-title":"Signal Transduct Target Ther"},{"key":"3815_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01899-4","volume":"22","author":"X Wu","year":"2023","unstructured":"Wu X, Li T, Jiang R, Yang X, Guo H, Yang R. Targeting MHC-I molecules for cancer: function, mechanism, and therapeutic prospects. Mol Cancer. 2023;22:194.","journal-title":"Mol Cancer"},{"key":"3815_CR51","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41392-025-02280-1","volume":"10","author":"M Tufail","year":"2025","unstructured":"Tufail M, Jiang C-H, Li N. Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches. Signal Transduct Target Ther. 2025;10:227.","journal-title":"Signal Transduct Target Ther"},{"key":"3815_CR52","doi-asserted-by":"crossref","unstructured":"Cai T, Ceccato T, Botti S, Kranz J, Verze P, Bonkat G et al. Impact of lifestyle and the microbiome on male lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol Focus. 2025;11:557-559.","DOI":"10.1016\/j.euf.2025.04.013"},{"key":"3815_CR53","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.3389\/fcimb.2024.1431088","volume":"14","author":"H Cao","year":"2024","unstructured":"Cao H, Zhang D, Wang P, Wang Y, Shi C, Wu H, et al. Gut microbiome: a novel preventive and therapeutic target for prostatic disease. Front Cell Infect Microbiol. 2024;14:2024.","journal-title":"Front Cell Infect Microbiol"},{"key":"3815_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2023.127596","volume":"281","author":"J Li","year":"2024","unstructured":"Li J, Li Y, Zhou L, Li C, Liu J, Liu D, et al. The human microbiome and benign prostatic hyperplasia: current understandings and clinical implications. Microbiol Res. 2024;281:127596.","journal-title":"Microbiol Res"},{"key":"3815_CR55","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3389\/fimmu.2025.1576679","volume":"16","author":"X Pei","year":"2025","unstructured":"Pei X, Liu L, Han Y. Advances in human microbiome and prostate cancer research. Front Immunol. 2025;16:2025.","journal-title":"Front Immunol"},{"key":"3815_CR56","first-page":"401","volume":"17","author":"O Zekraoui","year":"2025","unstructured":"Zekraoui O, Bhojani N, Zorn KC, Elterman D, Chughtai B. Management and treatment of benign prostatic hyperplasia symptoms: current insights. Res Rep Urol. 2025;17:401\u201320.","journal-title":"Res Rep Urol"},{"key":"3815_CR57","unstructured":"American Urological A. Diagnosis and Management of Male Chronic Pelvic Pain: AUA Guideline (Unabridged). AUA Clinical Guideline. Linthicum, MD: American Urological Association; 2025."},{"key":"3815_CR58","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s41232-025-00375-4","volume":"45","author":"F Wang","year":"2025","unstructured":"Wang F, Zhao C, Jing Z, Wang Q, Li M, Lu B, et al. The dual roles of chemokines in peripheral nerve injury and repair. Inflamm Regen. 2025;45:11.","journal-title":"Inflamm Regen"},{"key":"3815_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47640-7","volume":"15","author":"C Yin","year":"2024","unstructured":"Yin C, Liu B, Dong Z, Shi S, Peng C, Pan Y, et al. CXCL5 activates CXCR2 in nociceptive sensory neurons to drive joint pain and inflammation in experimental gouty arthritis. Nat Commun. 2024;15:3263.","journal-title":"Nat Commun"},{"key":"3815_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2024.104689","volume":"27","author":"M Vygonskaya","year":"2025","unstructured":"Vygonskaya M, Wu Y, Price TJ, Chen Z, Smith MT, Klyne DM, et al. The role and treatment potential of the complement pathway in chronic pain. J Pain. 2025;27:104689.","journal-title":"J Pain"},{"key":"3815_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1668173","volume":"16","author":"H Kang","year":"2025","unstructured":"Kang H, Chen Z, Wang B, Chen Z. The AhR\/IL-22 axis in chronic gut inflammation: unraveling mechanisms and therapeutic prospects. Front Immunol. 2025;16:1668173.","journal-title":"Front Immunol"},{"key":"3815_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2025.100316","volume":"11","author":"A Pang","year":"2025","unstructured":"Pang A, Pu S, Pan Y, Huang N, Li D. Short-chain fatty acids from gut microbiota restore Th17\/Treg balance in rheumatoid arthritis: mechanisms and therapeutic potential. J Transl Autoimmun. 2025;11:100316.","journal-title":"J Transl Autoimmun"},{"key":"3815_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-025-02191-x","volume":"13","author":"ZJ Lewis","year":"2025","unstructured":"Lewis ZJ, Scott A, Madden C, Vik D, Zayed AA, Smith GJ, et al. Evaluating urine volume and host depletion methods to enable genome-resolved metagenomics of the urobiome. Microbiome. 2025;13:199.","journal-title":"Microbiome"},{"key":"3815_CR64","doi-asserted-by":"publisher","first-page":"e00105","DOI":"10.1128\/jb.00105-25","volume":"207","author":"SA Reasoner","year":"2025","unstructured":"Reasoner SA, Francis J, Hadjifrangiskou M. The urinary microbiome: the next frontier of bacterial ecology. J Bacteriol. 2025;207:e00105\u201300125.","journal-title":"J Bacteriol"},{"key":"3815_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06519-x","volume":"23","author":"R Liu","year":"2025","unstructured":"Liu R, Lu J, Liu J, Liao Y, Guo Y, Shi P, et al. Macrophages in prostate cancer: dual roles in tumor progression and immune evasion. J Transl Med. 2025;23:615.","journal-title":"J Transl Med"},{"key":"3815_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41536-023-00339-7","volume":"8","author":"J Shen","year":"2023","unstructured":"Shen J, Wang Y, Zheng F, Cao S, Lan Q, Xu K, et al. Aryl hydrocarbon receptor regulates IL-22 receptor expression on thymic epithelial cell and accelerates thymus regeneration. npj Regenerat Med. 2023;8:64.","journal-title":"npj Regenerat Med"},{"key":"3815_CR67","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41392-024-02082-x","volume":"10","author":"J Chen","year":"2025","unstructured":"Chen J, Huang Z, Chen Y, Tian H, Chai P, Shen Y, et al. Lactate and lactylation in cancer. Signal Transduct Target Ther. 2025;10:38.","journal-title":"Signal Transduct Target Ther"},{"key":"3815_CR68","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41585-024-00869-9","volume":"21","author":"PHA Cao","year":"2024","unstructured":"Cao PHA, Dominic A, Lujan FE, Senthilkumar S, Bhattacharya PK, Frigo DE, et al. Unlocking ferroptosis in prostate cancer - the road to novel therapies and imaging markers. Nat Rev Urol. 2024;21:615\u201337.","journal-title":"Nat Rev Urol"},{"key":"3815_CR69","doi-asserted-by":"crossref","unstructured":"Xie W, Agarwal S, Yu J. Ferroptosis: the vulnerability within a cancer monster. J Clin Invest. 2023;133:e170027.","DOI":"10.1172\/JCI170027"},{"key":"3815_CR70","doi-asserted-by":"crossref","unstructured":"Parupathi P, Devarakonda LS, Francois E, Amjed M, Kumar A. Reprogrammed lipid metabolism-associated therapeutic vulnerabilities in prostate cancer. Int J Mol Sci. 2025;26:9132.","DOI":"10.3390\/ijms26189132"},{"key":"3815_CR71","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.7150\/ijbs.101039","volume":"20","author":"B Li","year":"2024","unstructured":"Li B, Cheng B, Huang H, Huang S, Yu S, Li Z, et al. Darolutamide-mediated phospholipid remodeling induces ferroptosis through the SREBP1-FASN axis in prostate cancer. Int J Biol Sci. 2024;20:4635\u201353.","journal-title":"Int J Biol Sci"},{"key":"3815_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01430-0","volume":"9","author":"J Liang","year":"2023","unstructured":"Liang J, Liao Y, Wang P, Yang K, Wang Y, Wang K, et al. Ferroptosis landscape in prostate cancer from molecular and metabolic perspective. Cell Death Discov. 2023;9:128.","journal-title":"Cell Death Discov"},{"key":"3815_CR73","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41391-023-00723-w","volume":"27","author":"L Wang","year":"2024","unstructured":"Wang L. Changes in the gut microbial profile during long-term androgen deprivation therapy for prostate cancer. Prostate Cancer Prostatic Dis. 2024;27:667\u201373.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"3815_CR74","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.3389\/fcimb.2023.1191126","volume":"13","author":"C Tsigalou","year":"2023","unstructured":"Tsigalou C, Paraschaki A, Bragazzi NL, Aftzoglou K, Stavropoulou E, Tsakris Z, et al. Alterations of gut microbiome following gastrointestinal surgical procedures and their potential complications. Front Cell Infect Microbiol. 2023;13:2023.","journal-title":"Front Cell Infect Microbiol"},{"key":"3815_CR75","doi-asserted-by":"crossref","unstructured":"Kouraki A, Zheng AS, Miller S, Kelly A, Ashraf W, Bazzani D et al. Metagenomic changes in response to antibiotic treatment in severe orthopedic trauma patients. iScience. 2024;27:110783.","DOI":"10.1016\/j.isci.2024.110783"},{"key":"3815_CR76","volume":"17","author":"NI Ruiz","year":"2025","unstructured":"Ruiz NI, Herrera Giron CG, Arragan Lezama CA, Frias Redroban SJ, Ventura Herrera MO, Sanic Coj GA. Timing and protocols for microbiome intervention in surgical patients: a literature review of current evidence. Cureus. 2025;17:e86104.","journal-title":"Cureus"},{"key":"3815_CR77","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s10020-024-00873-0","volume":"30","author":"L Lu","year":"2024","unstructured":"Lu L, Li F, Gao Y, Kang S, Li J, Guo J. Microbiome in radiotherapy: an emerging approach to enhance treatment efficacy and reduce tissue injury. Mol Med. 2024;30:105.","journal-title":"Mol Med"},{"key":"3815_CR78","doi-asserted-by":"crossref","unstructured":"Sharma S, Mohler J, Mahajan SD, Schwartz SA, Bruggemann L, Aalinkeel R. Microbial biofilm: a review on formation, infection, antibiotic resistance, control measures, and innovative treatment. Microorganisms. 2023;11:1614.","DOI":"10.3390\/microorganisms11061614"},{"key":"3815_CR79","first-page":"109","volume":"14","author":"GT Werneburg","year":"2022","unstructured":"Werneburg GT. Catheter-associated urinary tract infections: current challenges and future prospects. Res Rep Urol. 2022;14:109\u2013133.","journal-title":"Res Rep Urol"},{"key":"3815_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44095-0","volume":"15","author":"TM Nye","year":"2024","unstructured":"Nye TM, Zou Z, Obernuefemann CLP, Pinkner JS, Lowry E, Kleinschmidt K, et al. Microbial co-occurrences on catheters from long-term catheterized patients. Nat Commun. 2024;15:61.","journal-title":"Nat Commun"},{"key":"3815_CR81","doi-asserted-by":"publisher","DOI":"10.4240\/wjgs.v17.i2.97503","volume":"17","author":"Y Wu","year":"2025","unstructured":"Wu Y, Zhang X, Wang GQ, Jiao Y. Clinical significance of perioperative probiotic intervention on recovery following intestinal surgery. World J Gastrointest Surg. 2025;17:97503.","journal-title":"World J Gastrointest Surg"},{"key":"3815_CR82","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jss.2025.05.026","volume":"312","author":"C Paterson","year":"2025","unstructured":"Paterson C, Nikolic A, Glyn T, Eglinton T, Singh P, Hill A. Do perioperative probiotics\/synbiotics reduce postoperative infection rates following elective colorectal surgery? A systematic review and meta-analysis. J Surgical Res. 2025;312:163\u201376.","journal-title":"J Surgical Res"},{"key":"3815_CR83","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.clnu.2025.08.029","volume":"53","author":"A Weimann","year":"2025","unstructured":"Weimann A, Bezmarevic M, Braga M, Correia MITD, Funk-Debleds P, Gianotti L, et al. ESPEN guideline on clinical nutrition in surgery \u2013 Update 2025. Clin Nutr. 2025;53:222\u201361.","journal-title":"Clin Nutr"},{"key":"3815_CR84","unstructured":"Stanford University. Effect of preoperative diet on perioperative gut microbiome. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US); 2021. ClinicalTrials.gov identifier: NCT05027763. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05027763"},{"key":"3815_CR85","doi-asserted-by":"publisher","DOI":"10.1111\/codi.70106","volume":"27","author":"S Emoto","year":"2025","unstructured":"Emoto S, Inoue R, Murai S, Inagaki Y, Nozawa H, Sasaki K, et al. A pilot study of gut mucosal and faecal microbiota in rectal cancer: associations with histological response and adverse events following preoperative chemoradiotherapy. Colorectal Dis. 2025;27:e70106.","journal-title":"Colorectal Dis"},{"key":"3815_CR86","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1038\/s41416-022-01980-7","volume":"127","author":"SE Eaton","year":"2022","unstructured":"Eaton SE, Kaczmarek J, Mahmood D, McDiarmid AM, Norarfan AN, Scott EG, et al. Exploiting dietary fibre and the gut microbiota in pelvic radiotherapy patients. Br J Cancer. 2022;127:2087\u201398.","journal-title":"Br J Cancer"},{"key":"3815_CR87","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70481","volume":"15","author":"S Ma","year":"2025","unstructured":"Ma S, Li X, Shang S, Zhai Z, Wu M, Song Q, et al. Targeting gut microbiota and metabolites in cancer radiotherapy. Clin Transl Med. 2025;15:e70481.","journal-title":"Clin Transl Med"},{"key":"3815_CR88","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1663835","volume":"16","author":"Y Gao","year":"2025","unstructured":"Gao Y, Zeng B, Wang Z, Liang S, Yang Y. Faecalcrobiota metabolites: emerging insights into cancer radiotherapy outcomes. Front Microbiol. 2025;16:1663835.","journal-title":"Front Microbiol"},{"key":"3815_CR89","doi-asserted-by":"publisher","DOI":"10.4014\/jmb.2502.02037","volume":"35","author":"H Zhong","year":"2025","unstructured":"Zhong H, Song Y, Hu S, Zhang C, Li L. Metagenomics-metabolomics reveals the alleviation of indole-3-ethanol on radiation-induced enteritis in mice. J Microbiol Biotechnol. 2025;35:e2502037.","journal-title":"J Microbiol Biotechnol"},{"key":"3815_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105246","volume":"106","author":"J Iacovacci","year":"2024","unstructured":"Iacovacci J, Serafini MS, Avuzzi B, Badenchini F, Cicchetti A, Devecchi A, et al. Intestinal microbiota composition is predictive of radiotherapy-induced acute gastrointestinal toxicity in prostate cancer patients. EBioMedicine. 2024;106:105246.","journal-title":"EBioMedicine"},{"key":"3815_CR91","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41586-025-08994-0","volume":"643","author":"A Piffko","year":"2025","unstructured":"Piffko A, Yang K, Panda A, Heide J, Tesak K, Wen C, et al. Radiation-induced amphiregulin drives tumour metastasis. Nature. 2025;643:810\u20139.","journal-title":"Nature"},{"key":"3815_CR92","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2347722","volume":"16","author":"LW Xie","year":"2024","unstructured":"Xie LW, Cai S, Lu HY, Tang FL, Zhu RQ, Tian Y, et al. Microbiota-derived I3A protects the intestine against radiation injury by activating AhR\/IL-10\/Wnt signaling and enhancing the abundance of probiotics. Gut Microbes. 2024;16:2347722.","journal-title":"Gut Microbes"},{"key":"3815_CR93","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.tem.2023.05.006","volume":"34","author":"I Moraitis","year":"2023","unstructured":"Moraitis I, Guiu J, Rubert J. Gut microbiota controlling radiation-induced enteritis and intestinal regeneration. Trends Endocrinol Metab. 2023;34:489\u2013501.","journal-title":"Trends Endocrinol Metab"},{"key":"3815_CR94","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70608","volume":"31","author":"F Yang","year":"2025","unstructured":"Yang F, Liu Y, Zhou Z, Yang D, Yan W. Gut microbiota-bile acid-brain axis and TGR5-ERK1\/2 signaling mediate ADT-induced cognitive impairment. CNS Neurosci Ther. 2025;31:e70608.","journal-title":"CNS Neurosci Ther"},{"key":"3815_CR95","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.3390\/cancers16111991","volume":"16","author":"Y Chen","year":"2024","unstructured":"Chen Y, Lin P-H, Freedland SJ, Chi J-T. Metabolic response to androgen deprivation therapy of prostate cancer. Cancers. 2024;16:1991.","journal-title":"Cancers"},{"key":"3815_CR96","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.2147\/ITT.S549873","volume":"14","author":"M Abel","year":"2025","unstructured":"Abel M, Warner AB, Karzai F, Madan RA. Prostate cancer immunotherapy: time to move beyond checkpoint inhibitors. Immunotargets Ther. 2025;14:1041\u201352.","journal-title":"Immunotargets Ther"},{"key":"3815_CR97","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.euo.2025.04.016","volume":"8","author":"S van Wilpe","year":"2025","unstructured":"van Wilpe S, Taha T, Rothmann EC, Altshuler E, Park J, Ledet EM, et al. Efficacy of anti-PD-(L)1 immunotherapy in patients with DNA mismatch repair-deficient metastatic castration-resistant prostate cancer. Eur Urol Oncol. 2025;8:1020\u201329.","journal-title":"Eur Urol Oncol"},{"key":"3815_CR98","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13046-024-02962-8","volume":"43","author":"B Cheng","year":"2024","unstructured":"Cheng B, Li L, Luo T, Wang Q, Luo Y, Bai S, et al. Single-cell deconvolution algorithms analysis unveils autocrine IL11-mediated resistance to docetaxel in prostate cancer via activation of the JAK1\/STAT4 pathway. J Exp Clin Cancer Res. 2024;43:67.","journal-title":"J Exp Clin Cancer Res"},{"key":"3815_CR99","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-01034-0","volume":"9","author":"D B\u00f6hm","year":"2025","unstructured":"B\u00f6hm D, Russ E, Guchelaar HJ, Ziemons J, Penders J, Smidt ML, et al. The role of the gut microbiota in chemotherapy response, efficacy and toxicity: a systematic review. NPJ Precis Oncol. 2025;9:265.","journal-title":"NPJ Precis Oncol"},{"key":"3815_CR100","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jare.2023.11.027","volume":"64","author":"S Li","year":"2024","unstructured":"Li S, Zhu S, Yu J. The role of gut microbiota and metabolites in cancer chemotherapy. J Adv Res. 2024;64:223\u201335.","journal-title":"J Adv Res"},{"key":"3815_CR101","doi-asserted-by":"crossref","unstructured":"Yang C, Wang L, Gong C, Lv D, Li H, Huang Y et al. Antibody\u2011drug conjugates in prostate cancer: Emerging strategies to enhance therapeutic index and current clinical landscape (review). Oncol Rep. 2025;53:21.","DOI":"10.3892\/or.2024.8854"},{"key":"3815_CR102","volume":"15","author":"M Sardinha","year":"2023","unstructured":"Sardinha M, Palma Dos Reis AF, Barreira JV, Fontes Sousa M, Pacey S, Luz R. Antibody-drug conjugates in prostate cancer: a systematic review. Cureus. 2023;15:e34490.","journal-title":"Cureus"},{"key":"3815_CR103","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.clgc.2022.07.009","volume":"21","author":"G Mjaess","year":"2023","unstructured":"Mjaess G, Aoun F, Rassy E, Diamand R, Albisinni S, Roumegu\u00e8re T. Antibody-drug conjugates in prostate cancer: where are we? Clin Genitourin Cancer. 2023;21:171\u20134.","journal-title":"Clin Genitourin Cancer"},{"key":"3815_CR104","doi-asserted-by":"crossref","unstructured":"Wu J, Cheng B, Song Y, Cheng J, Gao H, Luo X et al. Targeting sialylation enhances the therapeutic efficacy of the nectin-4-targeted antibody-drug conjugate enfortumab vedotin in bladder cancer. Cancer Res. 2025.","DOI":"10.1158\/0008-5472.CAN-25-0024"},{"key":"3815_CR105","doi-asserted-by":"publisher","DOI":"10.1002\/eji.70000","volume":"55","author":"A O\u2019Neill","year":"2025","unstructured":"O\u2019Neill A, Zakaria N, Egan H, Treacy O, Hogan AM, O\u2019Dwyer M, et al. The Tumour Glyco-Code: Sialylation as a Mediator of Stromal Cell Immunosuppression in the Tumour Microenvironment. Eur J Immunol. 2025;55:e70000.","journal-title":"Eur J Immunol"},{"key":"3815_CR106","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202451318","volume":"55","author":"E Rodriguez","year":"2025","unstructured":"Rodriguez E. Tumor Glycosylation: A Main Player in the Modulation of Immune Responses. Eur J Immunol. 2025;55:e202451318.","journal-title":"Eur J Immunol"},{"key":"3815_CR107","doi-asserted-by":"publisher","DOI":"10.1177\/17588359231221337","volume":"16","author":"MT Bourlon","year":"2024","unstructured":"Bourlon MT, Valdez P, Castro E. Development of PARP inhibitors in advanced prostate cancer. Ther Adv Med Oncol. 2024;16:17588359231221337.","journal-title":"Ther Adv Med Oncol"},{"key":"3815_CR108","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/S0140-6736(24)01653-2","volume":"404","author":"MJ Morris","year":"2024","unstructured":"Morris MJ, Castellano D, Herrmann K, de Bono JS, Shore ND, Chi KN, et al. 177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial. Lancet. 2024;404:1227\u201339.","journal-title":"Lancet"},{"key":"3815_CR109","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37096-6","volume":"14","author":"J Patterson-Fortin","year":"2023","unstructured":"Patterson-Fortin J, Jadhav H, Pantelidou C, Phan T, Grochala C, Mehta AK, et al. Polymerase theta inhibition activates the cGAS-STING pathway and cooperates with immune checkpoint blockade in models of BRCA-deficient cancer. Nat Commun. 2023;14:1390.","journal-title":"Nat Commun"},{"key":"3815_CR110","doi-asserted-by":"crossref","unstructured":"Feigenberg SJ, Costabile F, Tanes C, Bittinger K, O\u2019Connor R, Agarwal D et al. Enhancing outcomes in medically inoperable early-stage NSCLC with gut-targeted antibiotics and stereotactic body radiotherapy: results from a randomized pilot study. J Immunother Cancer. 2025;13:e011356.","DOI":"10.1136\/jitc-2024-011356"},{"key":"3815_CR111","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ccell.2025.02.010","volume":"43","author":"J Chen","year":"2025","unstructured":"Chen J, Levy A, Tian AL, Huang X, Cai G, Fidelle M, et al. Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients. Cancer Cell. 2025;43:361\u201379.e310.","journal-title":"Cancer Cell"},{"key":"3815_CR112","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-023-00358-z","volume":"7","author":"E Gkika","year":"2023","unstructured":"Gkika E, Firat E, Adebahr S, Graf E, Popp I, Radicioni G, et al. Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer. NPJ Precis Oncol. 2023;7:24.","journal-title":"NPJ Precis Oncol"},{"key":"3815_CR113","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh JA, Goberdhan DCI, O\u2019Driscoll L, Buzas EI, Blenkiron C, Bussolati B, et al. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J Extracell Vesicles. 2024;13:e12404.","journal-title":"J Extracell Vesicles"},{"key":"3815_CR114","unstructured":"FDA. Clinical trials guidance documents. FDA Science & Research; 2024."},{"key":"3815_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49424-5","volume":"15","author":"A Khoo","year":"2024","unstructured":"Khoo A, Govindarajan M, Qiu Z, Liu LY, Ignatchenko V, Waas M, et al. Prostate cancer reshapes the secreted and extracellular vesicle urinary proteomes. Nat Commun. 2024;15:5069.","journal-title":"Nat Commun"},{"key":"3815_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217938","volume":"631","author":"B Cheng","year":"2025","unstructured":"Cheng B, Luo T, Wu Y, Hu J, Yang C, Wu J, et al. Urinary exosomal FAM153C-RPL19 chimeric RNA as a diagnostic and prognostic biomarker for prostate cancer in Chinese patients. Cancer Lett. 2025;631:217938.","journal-title":"Cancer Lett"},{"key":"3815_CR117","unstructured":"International Society for Extracellular V. ISEV Output. ISEV 2025."},{"key":"3815_CR118","doi-asserted-by":"publisher","first-page":"e078378","DOI":"10.1136\/bmj-2023-078378","volume":"385","author":"GS Collins","year":"2024","unstructured":"Collins GS, Moons KGM, Dhiman P, Riley RD, Beam AL, Van Calster B, et al. TRIPOD\u2009+\u2009AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ. 2024;385:e078378.","journal-title":"BMJ"},{"key":"3815_CR119","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.spinee.2021.02.024","volume":"21","author":"AJ Vickers","year":"2021","unstructured":"Vickers AJ, Holland F. Decision curve analysis to evaluate the clinical benefit of prediction models. Spine J. 2021;21:1643\u20138.","journal-title":"Spine J"},{"key":"3815_CR120","doi-asserted-by":"publisher","DOI":"10.1186\/s41512-023-00148-y","volume":"7","author":"AJ Vickers","year":"2023","unstructured":"Vickers AJ, Van Claster B, Wynants L, Steyerberg EW. Decision curve analysis: confidence intervals and hypothesis testing for net benefit. Diagnostic Prognostic Res. 2023;7:11.","journal-title":"Diagnostic Prognostic Res"},{"key":"3815_CR121","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-024-02135-w","volume":"20","author":"JD Mosley","year":"2024","unstructured":"Mosley JD, Dunn WB, Kuligowski J, Lewis MR, Monge ME, Ulmer Holland C, et al. Metabolomics 2023 workshop report: moving toward consensus on best QA\/QC practices in LC-MS-based untargeted metabolomics. Metabolomics. 2024;20:73.","journal-title":"Metabolomics"},{"key":"3815_CR122","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202201591R","volume":"37","author":"S Miyasato","year":"2023","unstructured":"Miyasato S, Iwata K, Mura R, Nakamura S, Yanagida K, Shindou H, et al. Constitutively active GPR43 is crucial for proper leukocyte differentiation. FASEB J. 2023;37:e22676.","journal-title":"FASEB J"},{"key":"3815_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2023.115599","volume":"235","author":"C Vagaggini","year":"2023","unstructured":"Vagaggini C, Brai A, Bonente D, Lombardi J, Poggialini F, Pasqualini C, et al. Development and validation of derivatization-based LC-MS\/MS method for quantification of short-chain fatty acids in human, rat, and mouse plasma. J Pharm Biomed Anal. 2023;235:115599.","journal-title":"J Pharm Biomed Anal"},{"key":"3815_CR124","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1039\/D4AN00296B","volume":"149","author":"G Zhang","year":"2024","unstructured":"Zhang G, Ding Y, Zhang H, Wei D, Liu Y, Sun J, et al. Assessment of urine sample collection and processing variables for extracellular vesicle-based proteomics. Analyst. 2024;149:3416\u201324.","journal-title":"Analyst"},{"key":"3815_CR125","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1124144","volume":"14","author":"M Calvigioni","year":"2023","unstructured":"Calvigioni M, Bertolini A, Codini S, Mazzantini D, Panattoni A, Massimino M, et al. HPLC-MS-MS quantification of short-chain fatty acids actively secreted by probiotic strains. Front Microbiol. 2023;14:1124144.","journal-title":"Front Microbiol"},{"key":"3815_CR126","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s13578-023-01157-6","volume":"13","author":"B Cheng","year":"2023","unstructured":"Cheng B, Li L, Wu Y, Luo T, Tang C, Wang Q, et al. The key cellular senescence related molecule RRM2 regulates prostate cancer progression and resistance to docetaxel treatment. Cell Biosci. 2023;13:211.","journal-title":"Cell Biosci"},{"key":"3815_CR127","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01493-1","volume":"22","author":"L Chang","year":"2024","unstructured":"Chang L, Li G, Jiang S, Li J, Yang J, Shah K, et al. 1-Pyrroline-5-carboxylate inhibit T cell glycolysis in prostate cancer microenvironment by SHP1\/PKM2\/LDHB axis. Cell Commun Signal. 2024;22:101.","journal-title":"Cell Commun Signal"},{"key":"3815_CR128","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41575-021-00440-6","volume":"18","author":"S Salminen","year":"2021","unstructured":"Salminen S, Collado MC, Endo A, Hill C, Lebeer S, Quigley EMM, et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol. 2021;18:649\u201367.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3815_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102530","volume":"298","author":"XX Wang","year":"2022","unstructured":"Wang XX, Xie C, Libby AE, Ranjit S, Levi J, Myakala K, et al. The role of FXR and TGR5 in reversing and preventing progression of Western diet-induced hepatic steatosis, inflammation, and fibrosis in mice. J Biol Chem. 2022;298:102530.","journal-title":"J Biol Chem"},{"key":"3815_CR130","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-88493-0","volume":"11","author":"S Miyata","year":"2021","unstructured":"Miyata S, Kawashima Y, Sakai M, Matsubayashi M, Motoki K, Miyajima Y, et al. Discovery, optimization, and evaluation of non-bile acid FXR\/TGR5 dual agonists. Sci Rep. 2021;11:9196.","journal-title":"Sci Rep"},{"key":"3815_CR131","doi-asserted-by":"publisher","first-page":"97","DOI":"10.38212\/2224-6614.3540","volume":"33","author":"S Pan","year":"2025","unstructured":"Pan S, Hsu JC, Hung KT, Ho CJ. Regulatory framework and challenges for live biotherapeutic products in Taiwan. J Food Drug Anal. 2025;33:97\u2013105.","journal-title":"J Food Drug Anal"},{"key":"3815_CR132","first-page":"2024","volume":"3","author":"D Barberio","year":"2024","unstructured":"Barberio D. Navigating regulatory and analytical challenges in live biotherapeutic product development and manufacturing. Front Microbiomes. 2024;3:2024.","journal-title":"Front Microbiomes"},{"key":"3815_CR133","unstructured":"Alacrita C. Live biotherapeutic products: landscape analysis. Alacrita Consulting, 2025."},{"key":"3815_CR134","doi-asserted-by":"crossref","unstructured":"Cheng B, Wang Q, Li Z, Luo T, Xie J, Singh S et al. Induction of ferroptosis in prostate cancer by CCDC7(19-13) via TRIM21-mediated ubiquitination of SLC7A11. Cell Death Differ. 2025.","DOI":"10.1038\/s41418-025-01580-x"},{"key":"3815_CR135","doi-asserted-by":"publisher","first-page":"7647","DOI":"10.1097\/JS9.0000000000002895","volume":"111","author":"B Cheng","year":"2025","unstructured":"Cheng B, Yang J, Huang W, Luo T, Li L, Wu J, et al. Regulation of macrophage plasticity by circCCDC7 19-13 through HSP90 inhibition suppresses prostate cancer progression and metastasis: a translational study. Int J Surg. 2025;111:7647\u201365.","journal-title":"Int J Surg"},{"key":"3815_CR136","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/tox.23997","volume":"39","author":"B Cheng","year":"2024","unstructured":"Cheng B, Lai Y, Huang H, Peng S, Tang C, Chen J, et al. MT1G, an emerging ferroptosis-related gene: a novel prognostic biomarker and indicator of immunotherapy sensitivity in prostate cancer. Environ Toxicol. 2024;39:927\u201341.","journal-title":"Environ Toxicol"},{"key":"3815_CR137","doi-asserted-by":"crossref","unstructured":"Chen H, Lyu F, Gao X. Advances in ferroptosis for castration-resistant prostate cancer treatment: novel drug targets and combination therapy strategies. Prostate Cancer Prostatic Dis. 2024.","DOI":"10.1038\/s41391-024-00933-w"},{"key":"3815_CR138","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06180-4","volume":"23","author":"H Yang","year":"2025","unstructured":"Yang H, Zhang X, Jia Z, Wang H, Wu J, Wei X, et al. Targeting ferroptosis in prostate cancer management: molecular mechanisms, multidisciplinary strategies and translational perspectives. J Transl Med. 2025;23:166.","journal-title":"J Transl Med"},{"key":"3815_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107915","volume":"219","author":"D Lv","year":"2025","unstructured":"Lv D, Shi Y, Kou L, Zhang D, Guo Y, Zhao S. Precision targeting of androgen receptor-ferroptosis crosstalk in prostate cancer: from mechanisms to therapeutic strategies. Pharm Res. 2025;219:107915.","journal-title":"Pharm Res"},{"key":"3815_CR140","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tim.2018.11.003","volume":"27","author":"R Eisenhofer","year":"2019","unstructured":"Eisenhofer R, Minich JJ, Marotz C, Cooper A, Knight R, Weyrich LS. Contamination in low microbial biomass microbiome studies: issues and recommendations. Trends Microbiol. 2019;27:105\u201317.","journal-title":"Trends Microbiol"},{"key":"3815_CR141","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1038\/s41587-023-01696-w","volume":"41","author":"GI Austin","year":"2023","unstructured":"Austin GI, Park H, Meydan Y, Seeram D, Sezin T, Lou YC, et al. Contamination source modeling with SCRuB improves cancer phenotype prediction from microbiome data. Nat Biotechnol. 2023;41:1820\u201328.","journal-title":"Nat Biotechnol"},{"key":"3815_CR142","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-018-0605-2","volume":"6","author":"NM Davis","year":"2018","unstructured":"Davis NM, Proctor DM, Holmes SP, Relman DA, Callahan BJ. Simple statistical identification and removal of contaminant sequences in marker-gene and metagenomics data. Microbiome. 2018;6:226.","journal-title":"Microbiome"},{"key":"3815_CR143","first-page":"2025","volume":"15","author":"J Zhang","year":"2025","unstructured":"Zhang J, Lei Y, Du H, Li Z, Wang X, Yang D, et al. Exploring urinary microbiome: insights into neurogenic bladder and improving management of urinary tract infections. Front Cell Infect Microbiol. 2025;15:2025.","journal-title":"Front Cell Infect Microbiol"},{"key":"3815_CR144","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.3389\/fcimb.2024.1364333","volume":"14","author":"B Shi","year":"2024","unstructured":"Shi B, Chen F, Gong J, Khan A, Qian X, Xu Z, et al. Urinary microbiome profiling as a non-invasive tool for identifying biomarkers in systemic lupus erythematosus and lupus nephritis. Front Cell Infect Microbiol. 2024;14:2024.","journal-title":"Front Cell Infect Microbiol"},{"key":"3815_CR145","doi-asserted-by":"publisher","unstructured":"Ayala-Monta\u00f1o S, Afolayan AO, Kociurzynski R, Loeber U, Reuter S. Identification and mitigation of microbial contaminant reads from long-read metagenomic samples. bioRxiv. 2024 Dec 1. https:\/\/doi.org\/10.1101\/2024.11.26.625374v2.","DOI":"10.1101\/2024.11.26.625374v2"},{"key":"3815_CR146","doi-asserted-by":"publisher","unstructured":"D\u00edaz S, Escobar JS, Avila FW. Identification and removal of potential contaminants in 16S rRNA gene sequence data sets from low-microbial-biomass samples: an example from mosquito tissues. mSphere. 2021;6: https:\/\/doi.org\/10.1128\/msphere.00506-00521.","DOI":"10.1128\/msphere.00506-00521"},{"key":"3815_CR147","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-014-0087-z","volume":"12","author":"SJ Salter","year":"2014","unstructured":"Salter SJ, Cox MJ, Turek EM, Calus ST, Cookson WO, Moffatt MF, et al. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol. 2014;12:87.","journal-title":"BMC Biol"},{"key":"3815_CR148","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1128\/JCM.05852-11","volume":"50","author":"AJ Wolfe","year":"2012","unstructured":"Wolfe AJ, Toh E, Shibata N, Rong R, Kenton K, Fitzgerald M, et al. Evidence of uncultivated bacteria in the adult female bladder. J Clin Microbiol. 2012;50:1376\u201383.","journal-title":"J Clin Microbiol"},{"key":"3815_CR149","first-page":"e23","volume":"45","author":"DM Tourlousse","year":"2017","unstructured":"Tourlousse DM, Yoshiike S, Ohashi A, Matsukura S, Noda N, Sekiguchi Y. Synthetic spike-in standards for high-throughput 16S rRNA gene amplicon sequencing. Nucleic Acids Res. 2017;45:e23.","journal-title":"Nucleic Acids Res"},{"key":"3815_CR150","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nature24460","volume":"551","author":"D Vandeputte","year":"2017","unstructured":"Vandeputte D, Kathagen G, D\u2019Hoe K, Vieira-Silva S, Valles-Colomer M, Sabino J, et al. Quantitative microbiome profiling links gut community variation to microbial load. Nature. 2017;551:507\u201311.","journal-title":"Nature"},{"key":"3815_CR151","doi-asserted-by":"publisher","DOI":"10.1038\/srep16350","volume":"5","author":"JM Choo","year":"2015","unstructured":"Choo JM, Leong LEX, Rogers GB. Sample storage conditions significantly influence faecal microbiome profiles. Sci Rep. 2015;5:16350.","journal-title":"Sci Rep"},{"key":"3815_CR152","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/978-1-0716-1518-8_6","volume":"2327","author":"C Marotz","year":"2021","unstructured":"Marotz C, Zuniga C, Zaramela L, Knight R, Zengler K. Host DNA depletion in saliva samples for improved shotgun metagenomics. Methods Mol Biol. 2021;2327:87\u201392.","journal-title":"Methods Mol Biol"},{"key":"3815_CR153","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00470-23","volume":"9","author":"VdS Duarte","year":"2024","unstructured":"Duarte VdS, Porcellato D. Host DNA depletion methods and genome-centric metagenomics of bovine hindmilk microbiome. mSphere. 2024;9:e0047023.","journal-title":"mSphere"},{"key":"3815_CR154","doi-asserted-by":"publisher","first-page":"5717","DOI":"10.1128\/AEM.01451-14","volume":"80","author":"K Kennedy","year":"2014","unstructured":"Kennedy K, Hall MW, Lynch MD, Moreno-Hagelsieb G, Neufeld JD. Evaluating bias of illumina-based bacterial 16S rRNA gene profiles. Appl Environ Microbiol. 2014;80:5717\u201322.","journal-title":"Appl Environ Microbiol"},{"key":"3815_CR155","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gks1219","volume":"41","author":"C Quast","year":"2013","unstructured":"Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2013;41:D590\u2013596.","journal-title":"Nucleic Acids Res"},{"key":"3815_CR156","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/nbt.4229","volume":"36","author":"DH Parks","year":"2018","unstructured":"Parks DH, Chuvochina M, Waite DW, Rinke C, Skarshewski A, Chaumeil PA, et al. A standardized bacterial taxonomy based on genome phylogeny substantially revises the tree of life. Nat Biotechnol. 2018;36:996\u20131004.","journal-title":"Nat Biotechnol"},{"key":"3815_CR157","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1128\/JCM.00044-16","volume":"54","author":"TK Price","year":"2016","unstructured":"Price TK, Dune T, Hilt EE, Thomas-White KJ, Kliethermes S, Brincat C, et al. The clinical urine culture: enhanced techniques improve detection of clinically relevant microorganisms. J Clin Microbiol. 2016;54:1216\u201322.","journal-title":"J Clin Microbiol"},{"key":"3815_CR158","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1210161","volume":"13","author":"NS Deen","year":"2023","unstructured":"Deen NS, Ahmed A, Tasnim NT, Khan N. Clinical relevance of expanded quantitative urine culture in health and disease. Front Cell Infect Microbiol. 2023;13:1210161.","journal-title":"Front Cell Infect Microbiol"},{"key":"3815_CR159","doi-asserted-by":"publisher","first-page":"E791","DOI":"10.1073\/pnas.1522149113","volume":"113","author":"JL Mark Welch","year":"2016","unstructured":"Mark Welch JL, Rossetti BJ, Rieken CW, Dewhirst FE, Borisy GG. Biogeography of a human oral microbiome at the micron scale. Proc Natl Acad Sci USA 2016;113:E791\u2013800.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3815_CR160","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41592-020-01033-y","volume":"18","author":"V Marx","year":"2021","unstructured":"Marx V. Method of the Year: spatially resolved transcriptomics. Nat Methods. 2021;18:9\u201314.","journal-title":"Nat Methods"},{"key":"3815_CR161","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41586-020-2881-9","volume":"587","author":"I Vujkovic-Cvijin","year":"2020","unstructured":"Vujkovic-Cvijin I, Sklar J, Jiang L, Natarajan L, Knight R, Belkaid Y. Host variables confound gut microbiota studies of human disease. Nature. 2020;587:448\u201354.","journal-title":"Nature"},{"key":"3815_CR162","doi-asserted-by":"publisher","first-page":"4137","DOI":"10.1016\/j.cell.2021.06.019","volume":"184","author":"HC Wastyk","year":"2021","unstructured":"Wastyk HC, Fragiadakis GK, Perelman D, Dahan D, Merrill BD, Yu FB, et al. Gut-microbiota-targeted diets modulate human immune status. Cell. 2021;184:4137\u201353.e4114.","journal-title":"Cell"},{"key":"3815_CR163","doi-asserted-by":"crossref","unstructured":"Schloss PD. Identifying and overcoming threats to reproducibility, replicability, robustness, and generalizability in microbiome research. mBio. 2018;9:e00525-18.","DOI":"10.1128\/mBio.00525-18"},{"key":"3815_CR164","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","volume":"165","author":"A Koh","year":"2016","unstructured":"Koh A, De Vadder F, Kovatcheva-Datchary P, B\u00e4ckhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell. 2016;165:1332\u201345.","journal-title":"Cell"},{"key":"3815_CR165","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/19490976.2015.1134082","volume":"7","author":"DJ Morrison","year":"2016","unstructured":"Morrison DJ, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 2016;7:189\u2013200.","journal-title":"Gut Microbes"},{"key":"3815_CR166","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","volume":"24","author":"A Wahlstr\u00f6m","year":"2016","unstructured":"Wahlstr\u00f6m A, Sayin SI, Marschall HU, B\u00e4ckhed F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 2016;24:41\u201350.","journal-title":"Cell Metab"},{"key":"3815_CR167","doi-asserted-by":"crossref","unstructured":"Ridlon JM. Conceptualizing the vertebrate sterolbiome. Appl Environ Microbiol. 2020;86:e00641\u201320.","DOI":"10.1128\/AEM.00641-20"},{"key":"3815_CR168","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.immuni.2013.08.003","volume":"39","author":"T Zelante","year":"2013","unstructured":"Zelante T, Iannitti RG, Cunha C, De Luca A, Giovannini G, Pieraccini G, et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity. 2013;39:372\u201385.","journal-title":"Immunity"},{"key":"3815_CR169","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05470-4","volume":"9","author":"HM Roager","year":"2018","unstructured":"Roager HM, Licht TR. Microbial tryptophan catabolites in health and disease. Nat Commun. 2018;9:3294.","journal-title":"Nat Commun"},{"key":"3815_CR170","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472:57\u201363.","journal-title":"Nature"},{"key":"3815_CR171","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nm.3145","volume":"19","author":"RA Koeth","year":"2013","unstructured":"Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19:576\u201385.","journal-title":"Nat Med"},{"key":"3815_CR172","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/iub.230","volume":"61","author":"AE Pegg","year":"2009","unstructured":"Pegg AE. Mammalian polyamine metabolism and function. IUBMB Life. 2009;61:880\u201394.","journal-title":"IUBMB Life"},{"key":"3815_CR173","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature13490","volume":"513","author":"OR Colegio","year":"2014","unstructured":"Colegio OR, Chu NQ, Szabo AL, Chu T, Rhebergen AM, Jairam V, et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature. 2014;513:559\u201363.","journal-title":"Nature"},{"key":"3815_CR174","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.688485","volume":"12","author":"HL Caslin","year":"2021","unstructured":"Caslin HL, Abebayehu D, Pinette JA, Ryan JJ. Lactate is a metabolic mediator that shapes immune cell fate and function. Front Physiol. 2021;12:688485.","journal-title":"Front Physiol"},{"key":"3815_CR175","doi-asserted-by":"publisher","first-page":"C440","DOI":"10.1152\/ajpcell.00411.2025","volume":"329","author":"L Huo","year":"2025","unstructured":"Huo L, Chen Q, Jia S, Zhang Y, Wang L, Li X, et al. Gut microbiome promotes succinate-induced ulcerative colitis by enhancing glycolysis through SUCNR1\/NF-\u03baB signaling pathway. Am J Physiol Cell Physiol. 2025;329:C440\u201354.","journal-title":"Am J Physiol Cell Physiol"},{"key":"3815_CR176","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1661948","volume":"16","author":"R Atallah","year":"2025","unstructured":"Atallah R, Gindlhuber J, Heinemann A. Succinate in innate immunity: linking metabolic reprogramming to immune modulation. Front Immunol. 2025;16:1661948.","journal-title":"Front Immunol"},{"key":"3815_CR177","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1464-410X.2009.08371.x","volume":"103","author":"KS Coyne","year":"2009","unstructured":"Coyne KS, Wein AJ, Tubaro A, Sexton CC, Thompson CL, Kopp ZS, et al. The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS. BJU Int. 2009;103:4\u201311.","journal-title":"BJU Int"},{"key":"3815_CR178","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/pcan.2016.8","volume":"19","author":"AS Polackwich","year":"2016","unstructured":"Polackwich AS, Shoskes DA. Chronic prostatitis\/chronic pelvic pain syndrome: a review of evaluation and therapy. Prostate Cancer Prostatic Dis. 2016;19:132\u20138.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"3815_CR179","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ucl.2007.09.005","volume":"35","author":"MA Pontari","year":"2008","unstructured":"Pontari MA. Chronic prostatitis\/chronic pelvic pain syndrome. Urol Clin North Am. 2008;35:81\u20139.","journal-title":"Urol Clin North Am"},{"key":"3815_CR180","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.cell.2018.09.006","volume":"175","author":"L Jerby-Arnon","year":"2018","unstructured":"Jerby-Arnon L, Shah P, Cuoco MS, Rodman C, Su MJ, Melms JC, et al. A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade. Cell. 2018;175:984\u201397.e924.","journal-title":"Cell"},{"key":"3815_CR181","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, et al. TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018;554:544\u20138.","journal-title":"Nature"},{"key":"3815_CR182","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1126\/science.aaf1490","volume":"351","author":"N McGranahan","year":"2016","unstructured":"McGranahan N, Furness AJ, Rosenthal R, Ramskov S, Lyngaa R, Saini SK, et al. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade. Science. 2016;351:1463\u20139.","journal-title":"Science"},{"key":"3815_CR183","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02264-5","volume":"21","author":"S Zhao","year":"2021","unstructured":"Zhao S, Li P, Wu W, Wang Q, Qian B, Li X, et al. Roles of ferroptosis in urologic malignancies. Cancer Cell Int. 2021;21:676.","journal-title":"Cancer Cell Int"},{"key":"3815_CR184","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature23007","volume":"547","author":"VS Viswanathan","year":"2017","unstructured":"Viswanathan VS, Ryan MJ, Dhruv HD, Gill S, Eichhoff OM, Seashore-Ludlow B, et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. 2017;547:453\u201357.","journal-title":"Nature"},{"key":"3815_CR185","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171:273\u201385.","journal-title":"Cell"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03815-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03815-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03815-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:12:42Z","timestamp":1779315162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03815-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":185,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2026,6,11]]}},"alternative-id":["3815"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03815-8","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}